Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens.
暂无分享,去创建一个
[1] S. Salminen,et al. Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. , 2008, FEMS microbiology letters.
[2] B. Aggarwal,et al. Probiotic Lactobacillus reuteri promotes TNF‐induced apoptosis in human myeloid leukemia‐derived cells by modulation of NF‐κB and MAPK signalling , 2008, Cellular microbiology.
[3] A. Hugo,et al. Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro , 2008, Letters in applied microbiology.
[4] R. Pridmore,et al. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. , 2008, FEMS microbiology letters.
[5] Jung Mogg Kim,et al. Conjugated linoleic acids produced by Lactobacillus dissociates IKK-γ and Hsp90 complex in Helicobacter pylori-infected gastric epithelial cells , 2008, Laboratory Investigation.
[6] A. Vestri,et al. Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells , 2008, Inflammatory bowel diseases.
[7] M. Kostrzynska,et al. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. , 2008, Journal of microbiological methods.
[8] K. Fellermann,et al. Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.
[9] A. Di Leo,et al. Antagonistic Activity of Potential Probiotic Lactobacilli Against the Ureolytic Pathogen Yersinia enterocolitica , 2008, Current Microbiology.
[10] E. Zoetendal,et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota , 2007, Alimentary pharmacology & therapeutics.
[11] R. Horvat. RESEARCH AND APPLICATIONS IN BACTERIOCINS , 2007 .
[12] C. Hill,et al. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. , 2007, FEMS immunology and medical microbiology.
[13] K. Whelan,et al. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials , 2007, Proceedings of the Nutrition Society.
[14] M. Griffiths,et al. Probiotics Affect Virulence-Related Gene Expression in Escherichia coli O157:H7 , 2007, Applied and Environmental Microbiology.
[15] C. Hill,et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 , 2007, Proceedings of the National Academy of Sciences.
[16] M. Schmidt,et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair , 2007, Cellular microbiology.
[17] F. Shanahan,et al. Gut microbiota: mining for therapeutic potential. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] A. Fanning,et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius , 2006, Immunology.
[19] M. Gotteland,et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? , 2006, Alimentary pharmacology & therapeutics.
[20] F. Kok,et al. Faecal SIgA secretion in infants fed on pre‐ or probiotic infant formula , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[21] G. Perdigón,et al. The Probiotic Bacterium Lactobacillus casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity , 2006, Clinical and Vaccine Immunology.
[22] A. Senok,et al. Probiotics: facts and myths. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[23] R. P. Ross,et al. Food microbiology: Bacteriocins: developing innate immunity for food , 2005, Nature Reviews Microbiology.
[24] T. Tompkins,et al. Probiotics Reduce Enterohemorrhagic Escherichia coli O157:H7- and Enteropathogenic E. coli O127:H6-Induced Changes in Polarized T84 Epithelial Cell Monolayers by Reducing Bacterial Adhesion and Cytoskeletal Rearrangements , 2005, Infection and Immunity.
[25] H. Tsen,et al. Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. , 2005, International journal of food microbiology.
[26] P. Sherman,et al. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. , 2005, The Journal of infectious diseases.
[27] A. Darfeuille‐Michaud,et al. Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent-Invasive Escherichia coli Isolated from Crohn's Disease Patients To Adhere to and To Invade Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.
[28] H. Qin,et al. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. , 2005, World journal of gastroenterology.
[29] M. Marinaro,et al. Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β-Bearing Regulatory Cells1 , 2005, The Journal of Immunology.
[30] S. Walsh,et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial , 2005, Gut.
[31] R. Sartor,et al. Probiotic therapy of intestinal inflammation and infections , 2005, Current opinion in gastroenterology.
[32] P. Brigidi,et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria , 2004, Gut.
[33] S. Nuding,et al. NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium , 2004, Infection and Immunity.
[34] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[35] Aristóbolo Mendes Silva,et al. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice , 2004, Journal of applied microbiology.
[36] N. Cerf-Bensussan,et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport , 2004, Gut.
[37] C. De Simone,et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. , 2004, Gastroenterology.
[38] T. Oelschlaeger,et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. , 2004, FEMS immunology and medical microbiology.
[39] Y. Takeda,et al. Probiotic Bifidobacteria Protect Mice from Lethal Infection with Shiga Toxin-Producing Escherichia coli O157:H7 , 2004, Infection and Immunity.
[40] C. Lacroix,et al. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes , 2003, Journal of applied microbiology.
[41] F. Guarner,et al. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. , 2003, The American journal of clinical nutrition.
[42] B. Sartor,et al. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when , 2003, Current opinion in gastroenterology.
[43] M. Hollingsworth,et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro , 2003, Gut.
[44] D. Teitelbaum,et al. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2002, Pediatric Surgery International.
[45] C. De Simone,et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.
[46] P. Gopal,et al. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. , 2001, International journal of food microbiology.
[47] F. Shanahan,et al. Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice , 2001, Alimentary pharmacology & therapeutics.
[48] F. Shanahan,et al. Probiotics in inflamatory bowel disease , 2001, Gut.
[49] W. Liu,et al. Isolation and characterization of a new bacteriocin from Lactobacillus gasseri KT7 , 2000, Journal of applied microbiology.
[50] I. Julkunen,et al. Lactobacilli and Streptococci Activate NF-κB and STAT Signaling Pathways in Human Macrophages1 , 2000, The Journal of Immunology.
[51] R. Rolfe. The role of probiotic cultures in the control of gastrointestinal health. , 2000, The Journal of nutrition.
[52] P. Brigidi,et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis , 1999, Alimentary pharmacology & therapeutics.
[53] M. Hollingsworth,et al. Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[54] Y. Koga,et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model , 1998, American Journal of Gastroenterology.
[55] T. Mitsuoka,et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. , 1998, International journal of food microbiology.
[56] Cook Si,et al. Review article: short chain fatty acids in health and disease , 1998 .
[57] J. H. I. Huis in't Veld,et al. Overview of gut flora and probiotics. , 1998, International journal of food microbiology.
[58] Y. Kim,et al. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. , 1994, Gastroenterology.
[59] M. Levitt,et al. Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. , 1984, The American journal of clinical nutrition.
[60] Hiroyuki Tanaka,et al. Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. , 2007, Allergology international : official journal of the Japanese Society of Allergology.
[61] S. Zanetti,et al. Mycobacterium avium sub. paratuberculosis in tissue samples of Crohn's disease patients. , 2004, The new microbiologica.
[62] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.